ScanSource (NASDAQ:SCSC) Releases Q1 2020 Earnings Guidance

Share on StockTwits

ScanSource (NASDAQ:SCSC) issued an update on its first quarter 2020 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.70-0.75 for the period, compared to the Thomson Reuters consensus estimate of $0.82. The company issued revenue guidance of $970M – 1.03 billion, compared to the consensus revenue estimate of $999.63 million.ScanSource also updated its Q1 guidance to $0.70-$0.75 EPS.

SCSC opened at $30.75 on Friday. The stock has a market cap of $803.71 million, a price-to-earnings ratio of 9.15 and a beta of 0.95. The stock’s 50 day moving average price is $32.16 and its 200-day moving average price is $34.57. ScanSource has a one year low of $28.40 and a one year high of $44.30. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.99 and a current ratio of 2.06.

ScanSource (NASDAQ:SCSC) last released its earnings results on Tuesday, August 20th. The industrial products company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.83 by ($0.12). The business had revenue of $960.80 million for the quarter, compared to the consensus estimate of $999.63 million. ScanSource had a net margin of 1.49% and a return on equity of 9.64%. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. As a group, analysts predict that ScanSource will post 3.67 earnings per share for the current fiscal year.

A number of research analysts have recently commented on SCSC shares. BidaskClub raised ScanSource from a sell rating to a hold rating in a research note on Friday, July 26th. ValuEngine cut ScanSource from a hold rating to a sell rating in a research note on Friday, May 10th. Northcoast Research cut ScanSource from a buy rating to a neutral rating in a research note on Monday, May 6th. TheStreet cut ScanSource from a b- rating to a c+ rating in a research note on Friday, May 17th. Finally, Raymond James dropped their price objective on ScanSource from $44.00 to $36.00 and set an outperform rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus target price of $39.00.

ScanSource Company Profile

ScanSource, Inc distributes technology products and solutions in North America, Latin America, and Europe. It operates in two segments, Worldwide Barcode, Networking & Security (WW Barcode, Networking & Security); and Worldwide Communications & Services (WW Communications & Services).

Read More: Technical Analysis of Stocks, How Can It Help

Earnings History and Estimates for ScanSource (NASDAQ:SCSC)

Receive News & Ratings for ScanSource Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ScanSource and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Citadel Advisors LLC Has $203.79 Million Position in Alliant Energy Co.
Citadel Advisors LLC Has $203.79 Million Position in Alliant Energy Co.
Bristol-Myers Squibb Co  Shares Purchased by New England Asset Management Inc.
Bristol-Myers Squibb Co Shares Purchased by New England Asset Management Inc.
New England Asset Management Inc. Has $25,000 Stake in General Electric
New England Asset Management Inc. Has $25,000 Stake in General Electric
New England Asset Management Inc. Invests $1.35 Million in Newmont Goldcorp Corp
New England Asset Management Inc. Invests $1.35 Million in Newmont Goldcorp Corp
New England Asset Management Inc. Grows Stock Holdings in Walt Disney Co
New England Asset Management Inc. Grows Stock Holdings in Walt Disney Co
New England Asset Management Inc. Has $1.69 Million Stock Position in Elanco Animal Health
New England Asset Management Inc. Has $1.69 Million Stock Position in Elanco Animal Health


© 2006-2019 Ticker Report